4//SEC Filing
Ekman Lars 4
Accession 0001140361-22-044319
CIK 0001559053other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 9:30 PM ET
Size
10.6 KB
Accession
0001140361-22-044319
Insider Transaction Report
Form 4
Ekman Lars
Director
Transactions
- Sale
Ordinary Shares, par value $0.01 per share
2022-12-01$61.28/sh−9,813$601,388→ 6,264 total - Exercise/Conversion
Stock Option (right to buy)
2022-12-01−15,834→ 15,834 totalExercise: $6.41Exp: 2023-01-29→ Ordinary Shares (15,834 underlying) - Sale
Ordinary Shares, par value $0.01 per share
2022-12-01$62.12/sh−6,021$374,018→ 243 total - Exercise/Conversion
Ordinary Shares, par value $0.01 per share
2022-12-01$6.41/sh+15,834$101,496→ 16,077 total
Footnotes (4)
- [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $60.65 to $61.6475, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 and 3 of this Form 4.
- [F3]The transaction was executed in multiple trades in prices ranging from $61.66 to $62.62, inclusive.
- [F4]The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.
Documents
Issuer
PROTHENA CORP PUBLIC LTD CO
CIK 0001559053
Entity typeother
Related Parties
1- filerCIK 0001376117
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 9:30 PM ET
- Size
- 10.6 KB